PAVmed
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $5 | $6 | $8 | $10 |
Gross Profit | -50 | -35 | -71 | -38 |
EBITDA | -5,981 | -12,298 | 18,670 | 1,218 |
EBIT | -6,003 | -12,320 | 18,627 | 1,149 |
Net Income | -5,383 | -11,921 | 18,968 | 1,431 |
Net Change In Cash | 5 | 6 | 8 | 10 |
Free Cash Flow | -899 | -1,186 | -1,587 | 90 |
Cash | 3,103 | 4,004 | 2,700 | 1,185 |
Basic Shares | 718 | 602 | 1,749 | 373 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,995 | $2,452 | $377 | $500 |
Gross Profit | -3,043 | -3,968 | -3,237 | -85 |
EBITDA | 29,670 | -75,742 | -99,500 | -55,900 |
EBIT | 28,472 | -78,674 | -101,957 | -56,126 |
Net Income | 39,791 | -64,175 | -88,983 | -50,347 |
Net Change In Cash | 2,995 | 2,452 | 377 | 500 |
Cost of Revenue | 60,002 | |||
Free Cash Flow | -33,609 | -52,278 | -72,525 | -42,060 |
Cash | 1,185 | 19,639 | 39,744 | 77,258 |
Basic Shares | 2,176 | 241 | 197 | 172 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.60 |
2025-06-30 | -$0.74 |
2025-03-31 | -$0.07 |
2024-12-31 | -$0.19 |
